Difference between revisions of "Avatrombopag (Doptelet)"

Revision as of 19:24, 29 October 2017

Thrombopoietin receptor agonist

Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. link to original article PubMed

@@ Line 4: / Line 4: @@
 ==Preliminary data==
 ===[[Autoimmune thrombocytopenic purpura (ITP)]]===
-<span
-style="background:#00CD00;
-padding:3px 6px 3px 6px;
-border-color:black;
-border-width:2px;
-border-style:solid;">Randomized Phase II, >20 per arm</span>
 # Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]
 ==Also known as==
-YM477, AKR 501
+*'''Code names:''' YM477, AKR 501
 [[Category:Drug index]]
+[[Category:Oral medications]]
 [[Category:Hematopoietic growth factors]]
 [[Category:Megakaryocyte growth factors]]